The Accomplishments of TGF-β Directed Therapies in Immuno-Oncology
Time: 9:00 am
day: Conference Day One
Details:
- Navigating from preclinical to clinical trials in immuno-oncology to maintain positive patient response
- Unearthing clinical efficacy and activity of TGF-β targeted therapy to celebrate success
- Discovering the next steps in the TGF-β space for clinical triumph
New Data!
